Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes? (Q38068232)

28 August 2017

1 reference

title

Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes? (English)

1 reference

28 August 2017

Jelle Matthijnssens

1

0 references

Marc Van Ranst

object named as

Marc Van Ranst

6

0 references

Max Ciarlet

4

object named as

Max Ciarlet

1 reference

28 August 2017

Osamu Nakagomi

2

1 reference

PubMed ID

23249234

28 August 2017

Carl D Kirkwood

3

1 reference

PubMed ID

23249234

28 August 2017

Ulrich Desselberger

5

1 reference

28 August 2017

1 November 2012

1 reference

Expert Review of Vaccines

28 August 2017

1 reference

28 August 2017

11

1 reference

28 August 2017

11

1 reference

28 August 2017

1347-1354

1 reference

Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains

28 August 2017

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Genotype constellation and evolution of group A rotaviruses infecting humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Zoonotic aspects of rotaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

The unpredictable diversity of co-circulating rotavirus types in Europe and the possible impact of universal mass vaccination programmes on rotavirus genotype incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Rotavirus infection in infants as protection against subsequent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Whole genome analysis of multiple rotavirus strains from a single stool specimen using sequence-independent amplification and 454® pyrosequencing reveals evidence of intergenotype genome segment recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Effect of zinc supplementation started during diarrhoea on morbidity and mortality in Bangladeshi children: community randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Vaccine-acquired rotavirus in infants with severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Interactions of diarrhea, pneumonia, and malnutrition in childhood: recent evidence from developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Modeling seasonal variation in rotavirus hospitalizations for use in evaluating the effect of rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

The genome segments of a group D rotavirus possess group A-like conserved termini but encode group-specific proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Modeling rotavirus strain dynamics in developed countries to understand the potential impact of vaccination on genotype distributions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Immune responses to rotavirus infection and vaccination and associated correlates of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Rotavirus immune responses and correlates of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Rotarix®: vaccine performance 6 years postlicensure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Rotavirus disease and vaccination: impact on genotype diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Distribution of rotavirus genotypes causing nosocomial and community-acquired acute gastroenteritis at the Children's Hospital of Philadelphia in the new rotavirus vaccine era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Emergence of human rotavirus genotype G9 in metropolitan Detroit between 2007 and 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Characterization of rotavirus and norovirus strains: a 6-year study (2004-2009).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Monitoring the circulation of rotavirus among children after the introduction of the Rotarix™ vaccine in Goiânia, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Laboratory-based rotavirus surveillance during the introduction of a vaccination program, Brazil, 2005-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Group A rotavirus genotypes and the ongoing Brazilian experience: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Rotavirus genotype distribution after vaccine introduction, Rio de Janeiro, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

One year environmental surveillance of rotavirus specie A (RVA) genotypes in circulation after the introduction of the Rotarix® vaccine in Rio de Janeiro, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Rapid changes in rotaviral genotypes in Ecuador

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Predominance of rotavirus G2P[4] and emergence of G12P[9] strains in Asunción, Paraguay, 2006-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

National Rotavirus Surveillance in Argentina: high incidence of G9P[8] strains and detection of G4P[6] strains with porcine characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Molecular epidemiology of group A rotavirus in Buenos Aires, Argentina 2004-2007: reemergence of G2P[4] and emergence of G9P[8] strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Impact of rotavirus vaccination on laboratory confirmed cases in Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Rotavirus surveillance in europe, 2005-2008: web-enabled reporting and real-time analysis of genotyping and epidemiological data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Immunity and correlates of protection for rotavirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Avian influenza: genetic evolution under vaccination pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Avian metapneumovirus (AMPV) attachment protein involvement in probable virus evolution concurrent with mass live vaccine introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Impact of rotavirus vaccination on childhood gastroenteritis-related mortality and hospital discharges in Panama.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Complete genome sequence analysis of candidate human rotavirus vaccine strains RV3 and 116E

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

VP6-sequence-based cutoff values as a criterion for rotavirus species demarcation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Effectiveness of Monovalent Rotavirus Vaccine (Rotarix) against Severe Diarrhea Caused by Serotypically Unrelated G2P[4] Strains in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Gastroenteritis outbreak due to G2P[4] rotavirus and GII norovirus at two correctional facilities in Brazil, 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

Impact of rotavirus vaccination on diarrhoea mortality and hospital admissions in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.12.105

21 January 2018

Identifiers

DOI

10.1586/ERV.12.105

1 reference

28 August 2017

1 reference

PubMed ID

23249234